Nuveen Asset Management Portfolio holdings
Nuveen Asset Management, founded in 1898 by John Nuveen and headquartered in Chicago, Illinois, is a leading global investment manager and subsidiary of TIAA, overseeing hundreds of billions in assets with a focus on fixed income, equities, and sustainable investing. Initially known for municipal bonds, Nuveen has expanded into a broad range of strategies, including mutual funds, ETFs, closed-end funds, and private capital solutions, serving institutional investors, financial advisors, and individuals. The firm emphasizes income-generating investments and ESG (environmental, social, governance) integration, leveraging its deep research capabilities and a century-long legacy in the bond market. With a strong presence in North America and growing international reach, Nuveen blends tradition with innovation to meet diverse client needs in the evolving investment landscape.
Top Buys
| 1 |
Alnylam Pharmaceuticals
ALNY
|
+$3.26B |
| 2 |
iShares Russell 1000 Growth ETF
IWF
|
+$268M |
| 3 |
Baxter International
BAX
|
+$212M |
| 4 |
UnitedHealth
UNH
|
+$185M |
| 5 |
Corteva
CTVA
|
+$169M |
Top Sells
| 1 |
Alphabet (Google) Class A
GOOGL
|
+$296M |
| 2 |
Microsoft
MSFT
|
+$260M |
| 3 |
Meta Platforms (Facebook)
META
|
+$251M |
| 4 |
Salesforce
CRM
|
+$226M |
| 5 |
Match Group
MTCH
|
+$188M |
Sector Composition
| 1 | Technology | 22.84% |
| 2 | Healthcare | 15.09% |
| 3 | Financials | 12.26% |
| 4 | Consumer Discretionary | 11.08% |
| 5 | Industrials | 8.21% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1126
Eagle Materials
EXP
$7.7B
| $16.8M | 0.01% |
156,638
+32,074
| +26% | +$3.44M |
|
|
RVNC
1127
DELISTED
Revance Therapeutics, Inc.
RVNC
| $16.7M | 0.01% |
619,164
+260,044
| +72% | +$7.02M |
|
1128
Ormat Technologies
ORA
$5.56B
| $16.7M | 0.01% |
193,825
+6,689
| +4% | +$577K |
|
|
PACW
1129
DELISTED
PacWest Bancorp
PACW
| $16.7M | 0.01% |
738,118
-208,664
| -22% | -$4.72M |
|
1130
Lear
LEA
$5.81B
| $16.7M | 0.01% |
139,241
+4,983
| +4% | +$596K |
|
1131
The Ensign Group
ENSG
$9.75B
| $16.7M | 0.01% |
209,511
-14,467
| -6% | -$1.15M |
|
1132
Iovance Biotherapeutics
IOVA
$876M
| $16.7M | 0.01% |
1,738,385
-60,164
| -3% | -$576K |
|
1133
Corebridge Financial
CRBG
$18.2B
| $16.6M | 0.01% |
+842,857
| New | +$16.6M |
|
1134
Organon & Co
OGN
$2.77B
| $16.5M | 0.01% |
706,993
+16,077
| +2% | +$376K |
|
1135
Highwoods Properties
HIW
$3.49B
| $16.5M | 0.01% |
612,453
+249,896
| +69% | +$6.74M |
|
1136
Eagle Bancorp
EGBN
$624M
| $16.5M | 0.01% |
368,267
+131,408
| +55% | +$5.89M |
|
1137
United Bankshares
UBSI
$5.4B
| $16.5M | 0.01% |
461,184
-39,261
| -8% | -$1.4M |
|
1138
Element Solutions
ESI
$6.37B
| $16.5M | 0.01% |
1,012,834
+30,657
| +3% | +$499K |
|
1139
Sangamo Therapeutics
SGMO
$160M
| $16.4M | 0.01% |
3,355,829
+2,267,632
| +208% | +$11.1M |
|
|
LSXMK
1140
DELISTED
Liberty Media Corporation Series C Liberty SiriusXM Common Stock
LSXMK
| $16.4M | 0.01% |
561,416
-50,448
| -8% | -$1.47M |
|
1141
First Bancorp
FBP
$3.54B
| $16.4M | 0.01% |
1,196,408
+11,360
| +1% | +$155K |
|
1142
ZTO Express
ZTO
$15.5B
| $16.3M | 0.01% |
678,351
-483,938
| -42% | -$11.6M |
|
1143
Sabra Healthcare REIT
SBRA
$4.59B
| $16.3M | 0.01% |
1,241,754
-50,426
| -4% | -$662K |
|
1144
CVR Energy
CVI
$3.2B
| $16.2M | 0.01% |
560,351
+55,890
| +11% | +$1.62M |
|
1145
iRhythm Technologies
IRTC
$5.82B
| $16.2M | 0.01% |
129,539
+5,949
| +5% | +$745K |
|
1146
Energy Recovery
ERII
$773M
| $16.2M | 0.01% |
743,683
-177,881
| -19% | -$3.87M |
|
1147
Phreesia
PHR
$1.53B
| $16.2M | 0.01% |
633,846
+116,504
| +23% | +$2.97M |
|
1148
Premier
PINC
$2.21B
| $16.1M | 0.01% |
475,740
+26,378
| +6% | +$895K |
|
1149
Houlihan Lokey
HLI
$14.6B
| $16.1M | 0.01% |
213,891
+3,222
| +2% | +$243K |
|
|
BCPC
1150
Balchem Corporation
BCPC
$5.17B
| $16.1M | 0.01% |
132,535
+3,840
| +3% | +$467K |
|